Compare PHIN & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHIN | QDEL |
|---|---|---|
| Founded | 2023 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | PHIN | QDEL |
|---|---|---|
| Price | $71.37 | $27.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 6 |
| Target Price | ★ $66.33 | $40.00 |
| AVG Volume (30 Days) | 367.0K | ★ 1.1M |
| Earning Date | 02-12-2026 | 02-11-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.18 | N/A |
| Revenue | ★ $3,427,000,000.00 | $2,714,400,000.00 |
| Revenue This Year | $3.00 | N/A |
| Revenue Next Year | $2.43 | $2.28 |
| P/E Ratio | $31.95 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $36.25 | $19.50 |
| 52 Week High | $72.04 | $44.68 |
| Indicator | PHIN | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 66.47 | 43.76 |
| Support Level | $69.60 | $26.50 |
| Resistance Level | $72.04 | $35.58 |
| Average True Range (ATR) | 1.74 | 2.00 |
| MACD | -0.26 | -0.58 |
| Stochastic Oscillator | 80.23 | 22.58 |
Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.